COGT
HEALTHYCogent Biosciences, Inc.
CIK: 0001622229
Strong Sell
(70% confidence)
Last activity: 3 weeks ago
Financial Metrics
As of Dec 31, 2024 (10-K)
Net Income -$34.53M
Total Cash $98.17M
Current Ratio 22.38
Insider Roster (5 total, 5 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| Fairmount Funds Management LLC DIRECTOR | 0 | 1 | -$127.40M | 5,503,418 shares $200.32M |
| Robinson John Edward Chief Scientific Officer | 0 | 1 | -$3.49M | 140,002 shares $5.42M |
| Sachs Jessica Chief Medical Officer | 0 | 1 | -$3.20M | 133,938 shares $5.18M |
| Green John L. Chief Financial Officer | 0 | 1 | -$2.98M | 131,834 shares $5.10M |
| Kearns Evan Chief Legal Officer | 0 | 1 | -$2.52M | 109,398 shares $4.23M |
Recent Transactions
SELL Fairmount Funds Management LLC (DIRECTOR)
3,500,000 shares @ $36.40
$127.40M
Jan 22, 2026
Conviction: |
View SEC Filing →
SELL Robinson John Edward (Chief Scientific Officer)
90,000 shares @ $38.74
$3.49M
Dec 26, 2025
Conviction: |
View SEC Filing →
SELL Sachs Jessica (Chief Medical Officer)
82,642 shares @ $38.70
$3.20M
Dec 26, 2025
Conviction: |
View SEC Filing →
SELL Green John L. (Chief Financial Officer)
77,000 shares @ $38.68
$2.98M
Dec 26, 2025
Conviction: |
View SEC Filing →
SELL Kearns Evan (Chief Legal Officer)
65,000 shares @ $38.70
$2.52M
Dec 26, 2025
Conviction: |
View SEC Filing →
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.